Peripheral blood natural killer cells activation status determined by CD69 upregulation predicts implantation outcome in IVF

被引:22
|
作者
Dons'koi, Boris V. [1 ]
Chernyshov, Viktor P. [1 ]
Sirenko, Vera Y. [2 ]
Strelko, Galina V. [3 ]
Osypchuk, Dariia V. [1 ]
机构
[1] Natl Acad Med Sci Ukraine, Inst Pediat Obstet & Gynecol, Immunol Lab, Kiev, Ukraine
[2] Inst Reprod Med, Kiev, Ukraine
[3] Inst Reprod Genet, Kiev, Ukraine
关键词
CD69; expression; Embryo implantation; Natural killer lymphocytes; NK activity; NK stimulation; RECURRENT SPONTANEOUS-ABORTIONS; IN-VITRO FERTILIZATION; LYMPHOID-CELLS; TARGET-CELLS; NK CELLS; WOMEN; CYTOTOXICITY; PREGNANCY; EXPRESSION; LYMPHOCYTES;
D O I
10.1016/j.imbio.2013.09.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Problem: NK lymphocytes play critical yet poorly defined role in implantation and during development in early pregnancy. Methods of study: Recently, we showed that the proportion of NK that expressed CD69(+) after incubation with 1(562 (CD69(stim)) cells reflected the NI(population excitation potential. In the present study, we investigate the significance of NK activation levels in predicting embryo implantation. Results:A qualitative analysis of values distribution in two groups showed that 25/33 (75.8%) women who became pregnant had CD69stim levels that were >30 but <60% (conditionally normal zone). In contrast, CD69stim levels in patients who failed to become pregnant were either elevated, as in 10/51 (19.6%), or reduced, as in 20/51 (39.2%) of the patients. Accentuated CD69stim levels were predictive for implantation failure, extremely significant for decreased (OR 6.9, p = 0.0004) and not quite significant for increased CD69stim levels (OR 3.9, p = 0.062). Accordingly, conditionally normal CD69stim levels were favourable for implantation (OR 4.46, p = 0.0032). Conclusion: We confirm that actual peripheral blood natural killer cells activation status have an influence on embryo implantation. We showed that exactly normal NI(cell activity predicting successful implantation. (C) 2013 Elsevier GmbH. All rights reserved.
引用
收藏
页码:167 / 171
页数:5
相关论文
共 42 条
  • [41] Adoptive immunotherapy with natural killer cells from peripheral blood CD34+ stem cells to prevent hepatocellular carcinoma recurrence after curative hepatectomy: a study protocol for an open-label, single-arm phase I study
    Ohira, Masahiro
    Kobayashi, Tsuyoshi
    Tanaka, Yuka
    Imaoka, Yuki
    Sato, Koki
    Imaoka, Koki
    Nakano, Ryosuke
    Doskali, Marlen
    Piao, Jinlian
    Nakamura, Mayuna
    Yoshida, Tetsumi
    Ichinohe, Tatsuo
    Kawano, Reo
    Yoshimura, Kenichi
    Ueda, Keiko
    Tamura, Natsuko
    Hirata, Taizo
    Imamura, Michio
    Aikata, Hiroshi
    Tanimine, Naoki
    Kuroda, Shintaro
    Tahara, Hiroyuki
    Ide, Kentaro
    Ohdan, Hideki
    BMJ OPEN, 2022, 12 (11):
  • [42] Phase I study of cellular therapy using ex vivo expanded natural killer cells from autologous peripheral blood mononuclear cells combined with rituximab-containing chemotherapy for relapsed CD20-positive malignant lymphoma patients
    Tanaka, Junji
    Tanaka, Norina
    Wang, Yan-Hua
    Mitsuhashi, Kenjiro
    Ryuzaki, Michiko
    Iizuka, Yuki
    Watanabe, Aya
    Ishiyama, Midori
    Shinohara, Akihito
    Kazama, Hiroshi
    Hagiwara, Shotaro
    Yoshinaga, Kentaro
    Kougen, Yumi
    Kobayashi, Hirohito
    Kanno, Hitoshi
    Shiseki, Masayuki
    HAEMATOLOGICA, 2020, 105 (04)